Showing results (1-10 of 652) with videos related to
Sort By:
Pageof 66
The American Journal of the Medical Sciences|October 12, 2011
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigationDavid Y Graham, Nicholas P Jewell, Francis K L ChanJournal of Gastroenterology and Hepatology|December 7, 2011
Anti-platelet therapy and managing ulcer riskFrancis K L ChanDrug Safety|March 24, 2005
NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient managementFrancis K L ChanChinese Journal of Digestive Diseases|January 26, 2005
Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Francis K L ChanCurrent Pharmaceutical Design|October 8, 2003
COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complicationsFrancis K L ChanThe American Journal of Gastroenterology|March 6, 2012
Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?Francis K L ChanDrugs|July 28, 2006
Management of high-risk patients on non-steroidal anti-inflammatory drugs or aspirinFrancis K L ChanNature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risksFrancis K L ChanEuropean Journal of Gastroenterology & Hepatology|January 10, 2002
Helicobacter pylori, NSAIDs and gastrointestinal haemorrhageFrancis K L ChanThe American Journal of Gastroenterology|September 29, 2007
The David Y. Graham lecture: use of nonsteroidal antiinflammatory drugs in a COX-2 restricted environmentFrancis K L ChanPageof 66